Patrick Griffin

Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies

Gautam Goel, Tim King, A. James M. Daveson et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 142 citations · Full text

Autoimmune Disease, Allergy, Epitope-specific Immunotherapy +10

A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation

Philip B. Miner, William Koltun, Gregory Wiener et al. · The American Journal of Gastroenterology · 2017 · 137 citations · Full text

Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials

Darren M. Brenner, Ronald Fogel, Spencer D. Dorn et al. · The American Journal of Gastroenterology · 2018 · 137 citations

Randomized clinical trial: efficacy and safety of plecanatide in the treatment of chronic idiopathic constipation

Michael DeMicco, Laura Barrow, Bernadette Hickey et al. · Therapeutic Advances in Gastroenterology · 2017 · 70 citations · Full text

Plecanatide, a Novel Uroguanylin Analog: A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate Efficacy and Safety in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Philip B. Miner, Robert DeLuca, Marianela La Portilla et al. · The American Journal of Gastroenterology · 2014 · 32 citations

Gastrointestinal Pharmacology, Gastroenterology, Csbm Frequency +18